<SEC-DOCUMENT>0001847903-22-000082.txt : 20221110
<SEC-HEADER>0001847903-22-000082.hdr.sgml : 20221110
<ACCEPTANCE-DATETIME>20221110070456
ACCESSION NUMBER:		0001847903-22-000082
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20221110
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221110
DATE AS OF CHANGE:		20221110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Centessa Pharmaceuticals plc
		CENTRAL INDEX KEY:			0001847903
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40445
		FILM NUMBER:		221374875

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT
		BUSINESS PHONE:		44 7391 789784

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR
		STREET 2:		1 ASHLEY ROAD
		CITY:			ALTRINCHAM, CHESHIRE
		STATE:			X0
		ZIP:			WA14 2DT

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Centessa Pharmaceuticals Ltd
		DATE OF NAME CHANGE:	20210224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cnta-20221110.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bef69806-2fa1-46e5-ae17-50ee5bd6d227,g:031e058e-a9b2-445b-9eb7-1d09308d795c,d:1ae4faa5c5cb456d945ff7da3db0924b--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:cnta="http://www.cnta.com/20221110" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnta-20221110</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl80L2ZyYWc6YjIyODNlY2UzNGYwNDBhYjkzOWUwYTA5MTE3OTlkNjYvdGFibGU6ZWU1M2U0MTIyYzhkNGU2M2ExYmVhZTExNjVkN2E2ODYvdGFibGVyYW5nZTplZTUzZTQxMjJjOGQ0ZTYzYTFiZWFlMTE2NWQ3YTY4Nl8wLTEtMS0xLTc5MjAw_7fd63b6a-3ec0-48d8-9712-0076ade67790">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl80L2ZyYWc6YjIyODNlY2UzNGYwNDBhYjkzOWUwYTA5MTE3OTlkNjYvdGFibGU6ZWU1M2U0MTIyYzhkNGU2M2ExYmVhZTExNjVkN2E2ODYvdGFibGVyYW5nZTplZTUzZTQxMjJjOGQ0ZTYzYTFiZWFlMTE2NWQ3YTY4Nl8xLTEtMS0xLTc5MjAw_5e555197-f182-4c4a-a8f9-b614ca7048a2">0001847903</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnta-20221110.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001847903</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-10</xbrli:startDate><xbrli:endDate>2022-11-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1ae4faa5c5cb456d945ff7da3db0924b_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6MmI2YzI5YzcxMzIzNDFjODkxM2JjOTY0YzQ2ZTYyM2QvdGFibGVyYW5nZToyYjZjMjljNzEzMjM0MWM4OTEzYmM5NjRjNDZlNjIzZF8wLTAtMS0xLTc5MjAwL3RleHRyZWdpb246YTZmZDZhNTBhNWFhNDk2MDgyNDM5ZTVhNTcwMWEwOTFfOQ_27b34136-1460-4dc6-ac7f-d02fcf9fbfc4">8-K</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported): <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8yMjE_3700b0d0-a8b0-4377-8c14-76eb2dbac189">November 10, 2022</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk5_0cbbab43-35ef-4b2b-98a2-78c4c01f4143">CENTESSA PHARMACEUTICALS PLC</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:20.029%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant, as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTAtMS0xLTc5MjAw_c7336306-71e3-478b-88b6-40955909e855">England and Wales</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTItMS0xLTc5MjAw_2aa2d8c5-ca1e-420e-8e8a-8e9adf3de6c8">001-04321</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTQtMS0xLTc5MjAw_5cb39cf4-69ff-4a8b-a991-8adea93708a1">98-1612294</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mailing address:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA1_f5c846e0-42e6-46a4-8bf1-2f8a9d04fd6f">3rd Floor</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkw_d3e933ff-a72e-4eb8-a354-0b54121cd9ef">1 Ashley Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressAddressLine3" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTAw_aa2403b1-11ad-44a6-a11a-0ff1415159ff">Altrincham</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkx_efb573ba-9436-4510-8241-3f7c7a649e24">Cheshire</ix:nonNumeric> <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA2_3438ac9a-93f9-469c-ab44-02ff6868d4a5">WA14 2DT</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkz_85ef4613-5b55-4b6d-b3ec-11d25a5dfcf3">United Kingdom</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODky_4903b9b8-c610-4dd4-80e8-f37ff76c35e4">+44</ix:nonNumeric> <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV81MTA_de5bac55-799f-4d39-b788-12de70fb6b58">(0) 203 920 6789</ix:nonNumeric><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk2_26369ec7-8b2f-4648-be3c-0943eb6957b2">, ext. 9999</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Former name or address, if changed since last report:&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA3_107f6526-4b75-4e7a-8e1c-affe3f673ad4">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTAy_037b37d1-7fc7-4e51-ac16-dcf49ff4ebd4">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODg4_598fd9a6-dd14-40f7-b389-e8a1a6e90051">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODg5_a0ca1558-587b-40d6-a46c-63c2eafc1fa7">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.412%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTAtMS0xLTc5MjAw_5f194f66-0500-4118-98ca-65d5393f0305">Ordinary shares, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTItMS0xLTc5MjAw_ea6a365b-3650-4732-bc16-c9faaf918d9a">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTQtMS0xLTc5MjAwL3RleHRyZWdpb246YmE3YzEyMTIxY2I5NDE4MDlhNjVhM2Y5MDI3MjA5YmVfNQ_704a2aac-2b8c-412e-b7f4-183a07dda501">Nasdaq Stock Market, LLC</ix:nonNumeric>*</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTAtMS0xLTc5MjAw_062e934d-01d0-431c-91ef-34ba41633725">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTItMS0xLTc5MjAw_e3612ecd-eb04-46f4-a6cb-8d5b7ef00943">CNTA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTQtMS0xLTc5MjAw_577a4ac5-e5e0-4937-9df9-ebb6403d0135">Nasdaq Stock Market, LLC</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market, LLC.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Emerging growth company <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk1_3b399baf-e9d0-41e4-9ac1-61ad7336054b">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA0_6cb6bede-aa7e-4424-b78e-d9023bef14cd">&#9744;</ix:nonNumeric></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i1ae4faa5c5cb456d945ff7da3db0924b_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 10, 2022, Centessa Pharmaceuticals plc (the &#8220;Company&#8221;) announced its financial results for the quarter ended September 30, 2022. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div id="i1ae4faa5c5cb456d945ff7da3db0924b_10"></div><div style="-sec-extract:summary;margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="cntapr-q32022.htm">Press Release dated November 10, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i1ae4faa5c5cb456d945ff7da3db0924b_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Date:&#160;&#160;&#160;&#160;November 10, 2022</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.591%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Saurabh Saha</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saurabh Saha, M.D., Ph.D.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cntapr-q32022.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic1867a3da8d844eca36b77afa2108d64_1"></div><div style="min-height:94.32pt;width:100%"><div style="margin-bottom:8pt;text-align:center"><img alt="letterheada.jpg" src="letterheada.jpg" style="height:71px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%"> Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%">Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:112%">Third Quarter of 2022</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%"> </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#8211; Company highlights three significant near-term milestones &#8211; </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#8211;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> Pivotal program for SerpinPC in hemophilia B advancing&#59;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> PRESent-5</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">o</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">bservation study on track to begin this quarter &#8211;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#8211; Data readout of SerpinPC </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Phase 2a OLE </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">Study</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">with </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">additional 18-months of continued subcutaneous treatment at </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">American Society of Hematology (ASH) Annual Meeting </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">in December 2022 &#8211; </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#8211; IND submission for LB101, a conditionally tetravalent PD-L1xCD47 bispecific monoclonal antibody, on track for late 2022 </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:112%">&#8211;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">&#8211; Cash runway into 2026 enables multiple clinical readouts across pipeline &#8211; </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#8211; Cash and cash equivalents of $444.8 million as of September 30, 2022 &#8211;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">BOSTON and LONDON, November </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">10,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> 2022&#58; </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%;text-decoration:underline">Centessa Pharmaceuticals plc</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> (Nasdaq&#58; CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today reported financial results and business highlights for the third quarter ended September 30, 2022. </font></div><div><font><br></font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8220;We </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">continue to execute and build momentum with our core programs,&#8221; said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. &#8220;With respect to our lead programs, SerpinPC and LB101, we remain focused on three potentially significant near-term milestones. First, we are advancing the pivotal program for SerpinPC with the initiation of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">PRESent-5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, an </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">observational feeder study, in the coming weeks. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">As an integral part of our registrational strategy, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">PRESent-5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> will collect prospective observational data for minimum defined periods before switching to dosing subjects in the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">PRESent-2 or PRESent-3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> interventional studies planned for 2023. The SerpinPC </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">r</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">egistrational dev</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">elopment program </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">represents an elegant and accelerated path forward</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">with the potential to bring a convenient, subcutaneous therapy to people with hemophilia B, as quickly as possible, subject to regulatory approval. Second, we are presenting the data readout from an </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">additional 18-months of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">continued treatment with subcutaneous doses of SerpinPC from the </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">open-label extension (OLE) of our Phase 2a Study </font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">at ASH on December 10, 2022.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> This key data readout will demonstrate the long-term effect of higher doses with SerpinPC in people with hemophilia.&#8221; </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font><br></font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Dr. Saha continued, &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Third, we are on track to submit the IND for LB101, our first LockBody&#174; candidate for solid tumors, late this year. We have continued to share encouraging non-clinical data which demonstrate the potential for an enhanced therapeutic index</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> and a well-tolerated safety profile,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> and w</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">e look forward to building on these data and initiating a</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> clinical trial for LB101 as quickly as possible subject to IND clearance. Lastly, we are well positioned with a </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">cash runway into 2026 that </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">supports</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">continued execution on these milestones and enables </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">multiple </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">clinical readouts across our pipeline.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Recent Highlights</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:12.53pt">In November, the Company announced that new data from the OLE of AP-0101, a Phase 2a study of SerpinPC, a novel inhibitor of activated protein C (APC), for the treatment of hemophilia, has been accepted for an oral presentation at ASH on December 10, 2022. The oral presentation will include efficacy, safety and tolerability data from 18-months of continued treatment with a subcutaneous injection of SerpinPC at a flat dose of 60 mg once every 4 weeks for 48 weeks, followed by 1.2 mg&#47;kg once every 2 weeks for 24 weeks, in subjects with hemophilia. The Company previously shared the results for the 6-month repeat-dose portion of the Phase 2a Study in September 2021.   </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:12.53pt">In September, SerpinPC was granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:12.53pt">In September, the Company presented non-clinical data from its oral small-molecule orexin receptor 2 (OX2R) agonist discovery pipeline at Sleep Europe 2022. The novel OX2R agonist compounds showed high potency in activating recombinant human and endogenous mouse OX2Rs, with more than a thousand-fold selectivity for OX2R compared to OX1R. The OX2R agonists also increased wakefulness and reduced cataplexy events in narcolepsy (NT1) model mice, and increased wakefulness in healthy mice.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%;padding-left:12.53pt">In September, the Company shared non-clinical pharmacokinetic and safety data in non-human primates for LB101, a conditionally tetravalent PD-L1xCD47 bispecific monoclonal antibody. Findings from these data reinforce the potential of the LockBody platform to minimize the systemic effects of potent immune effectors and significantly improve the therapeutic index. </font></div><div><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Anticipated Upcoming Program Milestones</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:13.8pt">Q4 2022&#58; SerpinPC - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Initiate </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">PRESent-5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, an observation feeder study for the planned intervention studies, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%">PRESent-2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> (moderately severe to severe hemophilia B without inhibitors, and severe hemophilia A with and without inhibitors)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">and</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:174%"> PRESent-3 </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">(hemophilia B with inhibitors).</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">Q4 2022&#58; SerpinPC - </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Phase 2a OLE data readout at ASH on December 10, 2022.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">Q4 2022&#58; LB101</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> - Investigational New Drug application (IND) submission.  </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">The Company continues to progress its earlier stage programs and where applicable, expects to provide updates as they enter clinical studies.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%"> </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Third Quarter 2022 Financial Results</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">Cash and Cash Equivalents&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> $444.8 million as of September 30, 2022, which the Company expects will fund operations into 2026, without drawing on the remaining available tranches under the Oberland credit facility.</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">Research &#38; Development Expenses&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> $36.7 million for the quarter ended September 30, 2022, compared to $25.9 million for the quarter ended September 30, 2021.</font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">General &#38; Administrative Expenses</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#58; $12.3 million for the quarter ended September 30, 2022, compared to $12.5 million the quarter ended September 30, 2021. </font></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%;padding-left:12.53pt">Net Loss Attributable to Ordinary Shareholders&#58;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%"> $53.9 million for the quarter ended September 30, 2022, compared to $40.2 million for the quarter ended September 30, 2021.</font></div><div style="margin-top:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">About Centessa Pharmaceuticals</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">&#8239; </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit </font><font style="color:#0000ff;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">www.centessa.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">, which does not form part of this release.  </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Forward Looking Statements </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">This press release contains forward-looking statements. These statements may be identified by words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;objective,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; &#8220;aim,&#8221; &#8220;seek,&#8221; and variations of these words or similar expressions that are intended to identify forward-looking statements. Any such statements in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including statements related to the Company&#8217;s ability to discover and develop transformational medicines for patients&#59; its expectations of achieving three significant near-term milestones, the timing of commencement of new studies or clinical trials&#59; the ability of our management team and board to drive momentum of the Company&#8217;s portfolio of programs&#59; research and clinical development plans and the timing thereof&#59; the scope, progress, results and costs of developing our product candidates or any other future product candidates&#59; the development and therapeutic potential of our product candidates, including SerpinPC, LB101, our LockBody platform and our OX2R agonist discovery pipeline&#59; regulatory matters, including the timing and likelihood of success of obtaining authorizations to initiate or continue clinical trials&#59;&#59; and our anticipated cash runway. Any forward-looking statements in this press release are based on our current expectations, estimates and projections only as of the date of this release and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, risks related to the safety and tolerability profile of our product candidates&#59; our ability to protect and maintain our intellectual property position&#59; business (including commercial viability), regulatory, economic and competitive risks, uncertainties, contingencies and assumptions about the Company&#59; risks inherent in developing product candidates and technologies&#59; future results from our ongoing and planned clinical trials&#59; our ability to obtain adequate financing, including through our financing facility with Oberland, to fund our planned clinical trials and other expenses&#59; trends in the industry&#59; the legal and regulatory framework for the industry, including the receipt and maintenance of clearances to conduct or continue clinical testing&#59; future expenditures risks related to our asset-centric corporate model&#59; the risk that any one or more of our product candidates will not be successfully developed and&#47;or commercialized&#59; the risk that the results of preclinical studies or clinical studies will not be predictive of future results in connection with future studies&#59; geo-political risks such as the Russia-Ukraine war and risks related to the ongoing COVID-19 pandemic including the effects of the Delta, Omicron and any other variants. These </font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">and other risks concerning our programs and operations are described in additional detail in our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and our other reports, which are on file with the U.S. Securities and Exchange Commission (SEC). We explicitly disclaim any obligation to update any forward-looking statements except to the extent required by law. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">Kristen K. Sheppard, Esq.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">SVP of Investor Relations</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:174%">investors&#64;centessa.com</font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Centessa Pharmaceuticals plc (Successor) and Centessa Predecessor Group (Predecessor)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Consolidated and Combined Statements of Operations and Comprehensive Loss</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(unaudited)</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands except share and per share data)</font></div><div style="margin-bottom:0.05pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Successor</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Predecessor</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three months ended September 30, 2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three months ended September 30, 2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Nine months ended September 30, 2022</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Period from<br>January 30, 2021<br>through <br>September 30, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Period from<br>January 1, 2021<br>through<br>January 29,<br>2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">36,744&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25,850&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">127,248&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">54,126&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">662&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,284&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">12,464&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,432&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">29,900&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">121&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Change in fair value of contingent value rights</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,980&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,312&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Acquired in-process research and development</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">220,454&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(49,028)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(38,314)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(170,660)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(315,792)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(783)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest (expense) income, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,845)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">65&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,869)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">100&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(9)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Amortization of debt discount</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(37)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other income (expense), net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(3,143)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,906)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,412&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,605)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss before income taxes</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(54,016)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(40,155)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(173,117)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(320,297)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(829)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Income taxes</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(141)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(83)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(53,875)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(40,155)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(173,034)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(320,297)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(829)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other comprehensive loss&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Foreign currency translation adjustment</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(553)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(487)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(2,383)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,828&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">107&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total comprehensive loss</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(54,428)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(40,642)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(175,417)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(317,469)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(722)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:13pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per ordinary share - basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.57)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.45)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1.86)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4.60)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted average ordinary shares outstanding - basic and diluted</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">94,327,914&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">89,899,454&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">92,994,990&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">69,597,648&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:0.05pt"><font><br></font></div><div style="margin-bottom:8pt;margin-top:0.05pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:94.32pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Centessa Pharmaceuticals plc (Successor)</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Condensed Consolidated Balance Sheets</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(unaudited)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(amounts in thousands)</font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">September 30, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2021</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">444,843&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">595,082&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">34,512&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">34,553&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">479,355&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">629,635&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other liabilities</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">38,234&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24,681&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Long term debt</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">68,200&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">75,700&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Contingent value rights</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">37,700&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">106,434&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">138,081&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total shareholders&#8217; equity</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">372,921&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">491,554&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and shareholders' equity</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">479,355&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">629,635&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><font><br></font></div><div style="height:103.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cnta-20221110.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bef69806-2fa1-46e5-ae17-50ee5bd6d227,g:031e058e-a9b2-445b-9eb7-1d09308d795c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cnta="http://www.cnta.com/20221110" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cnta.com/20221110">
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20221110_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20221110_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cnta-20221110_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cnta.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cnta_AmericanDepositarySharesMember" abstract="true" name="AmericanDepositarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>cnta-20221110_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bef69806-2fa1-46e5-ae17-50ee5bd6d227,g:031e058e-a9b2-445b-9eb7-1d09308d795c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20221110.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended" id="i355ff45cdd104cef89af8ddee30ee81b_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_41b136bd-3e1c-4a4a-8463-7f1619a91c91" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_DocumentType_41b136bd-3e1c-4a4a-8463-7f1619a91c91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8aa439f2-9bd1-4d99-9092-43aad7bbbcbe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_DocumentPeriodEndDate_8aa439f2-9bd1-4d99-9092-43aad7bbbcbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_617a7263-2101-4f48-93e8-1effeae1411f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityRegistrantName_617a7263-2101-4f48-93e8-1effeae1411f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bbf78699-100e-429e-99b2-5b9739bb9577" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bbf78699-100e-429e-99b2-5b9739bb9577" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_90ab4710-0d9f-4aef-9824-a300b565224d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityFileNumber_90ab4710-0d9f-4aef-9824-a300b565224d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9499108c-28d0-4110-970c-641f2fa3ae12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine1_9499108c-28d0-4110-970c-641f2fa3ae12" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_875e95fb-dfb5-4d37-b13a-072f964f589a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine2_875e95fb-dfb5-4d37-b13a-072f964f589a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_8abb9904-2ec2-4a42-b716-8295bd3c50cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine3_8abb9904-2ec2-4a42-b716-8295bd3c50cf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a4a87128-0618-441c-a113-e6491f7bae17" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressCityOrTown_a4a87128-0618-441c-a113-e6491f7bae17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1a811fec-301f-4861-8963-7ce32dd95e87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressPostalZipCode_1a811fec-301f-4861-8963-7ce32dd95e87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_0c7a4d46-1523-4e50-88aa-eeabdca402b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressCountry_0c7a4d46-1523-4e50-88aa-eeabdca402b8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_8ae79f55-ba4c-4dc4-8f96-3f80907a12d3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_CountryRegion_8ae79f55-ba4c-4dc4-8f96-3f80907a12d3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ca19e99e-eda2-4ae0-bdfd-1540b6a79675" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_CityAreaCode_ca19e99e-eda2-4ae0-bdfd-1540b6a79675" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b9d95757-90c5-4daa-8464-04a35e04ac3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_LocalPhoneNumber_b9d95757-90c5-4daa-8464-04a35e04ac3a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5c691582-7095-4dbb-a305-84772065e6a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_WrittenCommunications_5c691582-7095-4dbb-a305-84772065e6a4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e857893e-8c79-4cb1-acf3-de2dc1cd96da" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_SolicitingMaterial_e857893e-8c79-4cb1-acf3-de2dc1cd96da" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4e1169f6-dc27-47d0-b0fe-33d762640aa9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_PreCommencementTenderOffer_4e1169f6-dc27-47d0-b0fe-33d762640aa9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_98518144-9123-4c05-8a29-f857557729a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_98518144-9123-4c05-8a29-f857557729a9" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5434fff2-f45b-4795-bc54-31e846a8053a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_Security12bTitle_5434fff2-f45b-4795-bc54-31e846a8053a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cc76963f-500b-41fb-bf25-af4ee61862c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_TradingSymbol_cc76963f-500b-41fb-bf25-af4ee61862c4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a874961d-dfd8-4e39-a413-fcd26e55d0cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_SecurityExchangeName_a874961d-dfd8-4e39-a413-fcd26e55d0cf" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_79a56e70-3792-43e0-8f35-e5fc9a81ca34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityEmergingGrowthCompany_79a56e70-3792-43e0-8f35-e5fc9a81ca34" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_b1dd3cf2-1428-4640-b564-8a9a07b18dcd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityExTransitionPeriod_b1dd3cf2-1428-4640-b564-8a9a07b18dcd" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_64ede0ad-504c-4d65-bc5e-c506b7764587" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_AmendmentFlag_64ede0ad-504c-4d65-bc5e-c506b7764587" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a84b38af-55d4-43f9-96a7-8be8c3ea8e41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityCentralIndexKey_a84b38af-55d4-43f9-96a7-8be8c3ea8e41" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:to="loc_us-gaap_ClassOfStockDomain_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:to="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2174eaad-3620-4116-b61f-34d68fbb1709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:to="loc_us-gaap_CommonStockMember_2174eaad-3620-4116-b61f-34d68fbb1709" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_3cd30ee4-a63d-49b0-be03-0545903e8a4b" xlink:href="cnta-20221110.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:to="loc_cnta_AmericanDepositarySharesMember_3cd30ee4-a63d-49b0-be03-0545903e8a4b" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cnta-20221110_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bef69806-2fa1-46e5-ae17-50ee5bd6d227,g:031e058e-a9b2-445b-9eb7-1d09308d795c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d61c3dfc-df25-48b0-8161-cec20c6a46b7_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a77b9166-f743-4d90-ba52-a1b15b1fdb49_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c412dcf5-7cd0-4918-9c56-edbb81aeaf0e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_165b9f40-0ab3-422b-8b90-77cea30b5f92_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_39f3f1b0-dc43-44ba-a882-53271b4fb72b_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_99dc43e2-427d-4cef-9d9f-0fcd71208e4d_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_6513c79f-bdb9-490b-8826-61518c5622e6_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_074a4fb1-5430-431e-81d6-09584d1e743a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_2ea07d19-1cbd-4574-9f95-d07de31fe0f5_terseLabel_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_label_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares [Member]</link:label>
    <link:label id="lab_cnta_AmericanDepositarySharesMember_documentation_en-US" xlink:label="lab_cnta_AmericanDepositarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">American Depositary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember" xlink:href="cnta-20221110.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cnta_AmericanDepositarySharesMember" xlink:to="lab_cnta_AmericanDepositarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7b0eea15-d59e-473e-9e35-f8602555e75a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bbaa4fa6-d183-4c19-9942-245d55040711_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6509071d-ad51-489d-a048-392746c0cd63_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_393d07f0-518f-4755-aa67-041c359b46fe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_7d70e4c0-fa10-4565-a55c-85f466536074_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_e5a51d30-9072-4317-870b-6a2beb126507_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine3_467e93dc-3a12-404d-a426-b50c7930fce2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine3_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine3" xlink:to="lab_dei_EntityAddressAddressLine3" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_351eb533-73b4-41a9-a3a0-bf64e422d3af_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_d6ba729a-5fbe-4e19-aea5-57fb3fef10da_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b867c38e-1d16-4411-876c-683c33616c41_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ed2e1268-eb3e-4a8d-8be4-9081a8c028cb_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7dbd1442-6505-40c8-9477-0b61647d5720_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_2c6f1d86-83de-4991-9b67-4bf11208c9fa_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_9efecb3d-03f3-4225-b6d4-49fa1b7762a5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_08781efd-eaee-4c4c-80e2-479853de1f39_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_24a249ad-cb28-4f49-b155-d71a315a3614_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f2026c2-d89f-4627-8dcf-07285738b16a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_bde7610d-c76c-4b76-9dab-9736b4950072_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_2d162275-8143-44bd-95d9-236003ff08ba_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_15ab2de5-e92e-488a-9f31-a1737dec2ccc_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c154a2c3-cdb6-4b8a-b8a1-4cf8c1e7dc6e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_143ecedc-836d-4844-ab7f-a61f04b75451_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6925f025-f864-4cd5-8076-ea2e2441377d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cnta-20221110_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bef69806-2fa1-46e5-ae17-50ee5bd6d227,g:031e058e-a9b2-445b-9eb7-1d09308d795c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cnta.com/role/Cover" xlink:type="simple" xlink:href="cnta-20221110.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cnta.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_31642715-6d8e-435f-ad66-de5eadc8406b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_31642715-6d8e-435f-ad66-de5eadc8406b" xlink:to="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b403a3b6-e4d0-46b3-b437-a4a2442f7b3f" xlink:to="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2174eaad-3620-4116-b61f-34d68fbb1709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:to="loc_us-gaap_CommonStockMember_2174eaad-3620-4116-b61f-34d68fbb1709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cnta_AmericanDepositarySharesMember_3cd30ee4-a63d-49b0-be03-0545903e8a4b" xlink:href="cnta-20221110.xsd#cnta_AmericanDepositarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2a44524e-ffd0-4046-99f6-487ac886eb98" xlink:to="loc_cnta_AmericanDepositarySharesMember_3cd30ee4-a63d-49b0-be03-0545903e8a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_344d9d00-124d-40a3-b1a3-0f02c53f58f4" xlink:to="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_41b136bd-3e1c-4a4a-8463-7f1619a91c91" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_DocumentType_41b136bd-3e1c-4a4a-8463-7f1619a91c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8aa439f2-9bd1-4d99-9092-43aad7bbbcbe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_DocumentPeriodEndDate_8aa439f2-9bd1-4d99-9092-43aad7bbbcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_617a7263-2101-4f48-93e8-1effeae1411f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityRegistrantName_617a7263-2101-4f48-93e8-1effeae1411f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bbf78699-100e-429e-99b2-5b9739bb9577" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bbf78699-100e-429e-99b2-5b9739bb9577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_90ab4710-0d9f-4aef-9824-a300b565224d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityFileNumber_90ab4710-0d9f-4aef-9824-a300b565224d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_9499108c-28d0-4110-970c-641f2fa3ae12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine1_9499108c-28d0-4110-970c-641f2fa3ae12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_875e95fb-dfb5-4d37-b13a-072f964f589a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine2_875e95fb-dfb5-4d37-b13a-072f964f589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine3_8abb9904-2ec2-4a42-b716-8295bd3c50cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressAddressLine3_8abb9904-2ec2-4a42-b716-8295bd3c50cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a4a87128-0618-441c-a113-e6491f7bae17" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressCityOrTown_a4a87128-0618-441c-a113-e6491f7bae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1a811fec-301f-4861-8963-7ce32dd95e87" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressPostalZipCode_1a811fec-301f-4861-8963-7ce32dd95e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_0c7a4d46-1523-4e50-88aa-eeabdca402b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityAddressCountry_0c7a4d46-1523-4e50-88aa-eeabdca402b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_8ae79f55-ba4c-4dc4-8f96-3f80907a12d3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_CountryRegion_8ae79f55-ba4c-4dc4-8f96-3f80907a12d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ca19e99e-eda2-4ae0-bdfd-1540b6a79675" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_CityAreaCode_ca19e99e-eda2-4ae0-bdfd-1540b6a79675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b9d95757-90c5-4daa-8464-04a35e04ac3a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_LocalPhoneNumber_b9d95757-90c5-4daa-8464-04a35e04ac3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_5c691582-7095-4dbb-a305-84772065e6a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_WrittenCommunications_5c691582-7095-4dbb-a305-84772065e6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e857893e-8c79-4cb1-acf3-de2dc1cd96da" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_SolicitingMaterial_e857893e-8c79-4cb1-acf3-de2dc1cd96da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_4e1169f6-dc27-47d0-b0fe-33d762640aa9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_PreCommencementTenderOffer_4e1169f6-dc27-47d0-b0fe-33d762640aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_98518144-9123-4c05-8a29-f857557729a9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_98518144-9123-4c05-8a29-f857557729a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5434fff2-f45b-4795-bc54-31e846a8053a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_Security12bTitle_5434fff2-f45b-4795-bc54-31e846a8053a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cc76963f-500b-41fb-bf25-af4ee61862c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_TradingSymbol_cc76963f-500b-41fb-bf25-af4ee61862c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a874961d-dfd8-4e39-a413-fcd26e55d0cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_SecurityExchangeName_a874961d-dfd8-4e39-a413-fcd26e55d0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_79a56e70-3792-43e0-8f35-e5fc9a81ca34" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityEmergingGrowthCompany_79a56e70-3792-43e0-8f35-e5fc9a81ca34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_b1dd3cf2-1428-4640-b564-8a9a07b18dcd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityExTransitionPeriod_b1dd3cf2-1428-4640-b564-8a9a07b18dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_64ede0ad-504c-4d65-bc5e-c506b7764587" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_AmendmentFlag_64ede0ad-504c-4d65-bc5e-c506b7764587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a84b38af-55d4-43f9-96a7-8be8c3ea8e41" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_f03be216-14c7-4d76-a44c-0cd2053abadd" xlink:to="loc_dei_EntityCentralIndexKey_a84b38af-55d4-43f9-96a7-8be8c3ea8e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b0e9783c-0215-4a26-be20-7d4498077d3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_31642715-6d8e-435f-ad66-de5eadc8406b" xlink:to="loc_dei_EntityTaxIdentificationNumber_b0e9783c-0215-4a26-be20-7d4498077d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>letterheada.jpg
<TEXT>
begin 644 letterheada.jpg
M_]C_X  02D9)1@ ! 0$"6 )8  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BC-&: "BC-&: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHS1F@ HHS1F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ5B8^3/>OUT_X+L?\$[I?'VCO\9O!]BTVK:3"$\2VL0RUS;(N$NP.[1+P_\
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M;Z(/#)%(C\AE;<#4U=":>QRM-.S"BBBF(**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5C<I<0N0<$!T)4X-7*E-+FDM#".)I3GR1DKFY10.E%0;A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!Y% $9/O\
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M\WY]ET]05<>F/Y5E^*_%NF^!/#EUJVK75O8:?8QM-//,VU(T'4DT>+O%NG>
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M1SA>OF+B_)R?ZH_#,?\ !9;]IC_HHUY_X)[#_P"1Z/\ A\M^TJC[C\1KE?\
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M@*D(RC2A]R/Y9K9YFU*I*G/$3O'^\_\ ,^BF_P""K?[1.[CXG>(#_P!LXO\
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MV#&2:N@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M516[NH ^6DSFOYOE)RES2/[6HTU3@J<=D/!R**!Q14F@4444 %%%% !1110
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MK6GPW5G<0W=K<()8YXG#I(AY!5AP15RO@=5HS]?C)-70449S10,*.M%% #'
M%?BY_P '#_PNG\,?M8^'?%"QD67B;0DB#8^]/;RNKC_OB2'\Z_:1UZ5\P_\
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M/6G,V:^9_P#@JS^U./V3OV/_ !!JEI<^1K^OC^QM'VMAUGF5@9!_USC#O]5
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M///WJLMW^B_K4_AOQ(\2,7Q+BN2'N8>'PQ[^<O/MV^]N3K1117V1^9!1110
M4444 %%%% !1110 4444 -/!K\.?^"__ (N;Q'^WBUCYC%=#T&SM H[%C)/_
M .UJ_<53DU^!/_!;*X:7_@I)X^W'/EKIZK]!86YK[C@&ES9DY=H/\T?E?B]5
M<<EC&/VIK\FSY0Z5^AG_  ;E^'TO/VK/%VI,NY[+PR\"'^[ON;<_^TZ_/,G)
MK])/^#;K9_PO+XA;A^]_L6':?;SQG_V6OT;BN364UO3]4?BWA_'FS_#*7?\
M1G["44"BOP$_KT**** "BBB@ HHHH **** "BBB@!IZK7XB_\'#7_)]6F_\
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MRB.HHHKX<_51K=37P3_P<2?\F2Z/_P!C7:_^DUW7WLW4U\$_\'$G_)DNC_\
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MYL_FW&?\EXO^OD?R1^XE%%%?CY_204444 %%%% #6ZU\2_\ !?7_ ),$N/\
ML.6?_M2OMINM?$O_  7U_P"3!+C_ +#EG_[4KVN'?^1G0_Q+\SYGC'_D28K_
M  /\C\,SUKZ$_P""5'_*0OX7?]A8_P#HJ2OGL]:^A/\ @E1_RD+^%W_86/\
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M^!\'8I8;.L-4EMSK\=/U/Z"Z* <BC.:_GD_LH**** "BBB@ HHHH **,T9H
M**** &GJM?B+_P '#7_)]6F_]BG9_P#I3=U^W1ZK7XB_\'#7_)]6F_\ 8IV?
M_I3=U]GP'_R-%_A?Z'YAXM?\B/\ [?C^I\)]J_6/_@VE_P"1<^+?_7QIG\KN
MOR<[5^L?_!M+_P BY\6_^OC3/Y7=?H/&W_(IJ_\ ;O\ Z4C\>\,?^2BH_P#;
MW_I+/U%HHHK\+/ZP#%1S1+<0LKA65A@@C@U)0>E'FA-)JS/R6^#/[/6G_LV?
M\%_;70=&ACMM#O!>ZK80(-J6\=QIL[M$!_"JR%PJ_P!U5K]8TXQV'-<C=? ;
MP;??%BW\<3^&M'D\8647DP:NUNK7<2;&3:)/O;=KL/\ @1KLAR*];.,S^NRI
MS>\8*+\VNI\YPWD/]EPK4U;EG4<U;HG;3\!PZ4445Y)](-;J:^"?^#B3_DR7
M1_\ L:[7_P!)KNOO9NIKX)_X.)/^3)='_P"QKM?_ $FNZ]KAO_D9T/\ $?*\
M<?\ (CQ/^$_*_P#X)_\ _)[_ ,)/^QLTW_TIBK^D=/N#Z5_-Q_P3_P#^3W_A
M)_V-FF_^E,5?TCI]P?2OI_$;_>Z7^']3X7P9_P"1?7_Q_H+BBB@]*_/C]D(^
MOO7YF_\ !;7_ ()E+X[TV\^,7@/3O^)U81^9XET^!/FOH5'_ !](!_RT1?O_
M -Y5W=5.[],LXV_-1*BRAE(##N#7H95FE; 8A8BC_P .NQX?$&18?-L%+"8A
M;[/L^Z/Y7,?+76?!#XT^(OV?/BEH_B_PO?2:?K6AS":"0?,K?PLCC^)&4E67
M^)6:OL__ (+,_P#!,D_LX>++CXE>";#'@37+G_3[2!/ET.Y<] O\,#M]W^%6
M^3Y?DW? N"5SZ5^^8#'8?,L(JL-82_IIG\DYKE>,R3'NA5TG!Z/\FC^CK]AO
M]L_P_P#MM? ^P\5:0T=OJ$0$&KZ;OS)IUSCYD_VD;[R-_$OHP91[0HW=J_G(
M_8+_ &U]>_8;^.%GXFTLR76D76VUUG3-^U+^VSR/:1?O(W\+?[+,K?T&_!OX
MP:#\>/AGH_B[PS?1ZEHFM6XN+>=3SSU1AV=6#*RG[K*17XWQ1P_++:_-3_AR
MV\O(_I/@/C"&<X3DK?QH;^?FOU[/Y'Y3_P#!R)_R7SP#_P!@&7_TH>N!_P"#
M?3_D_67_ +%J\_\ 1D%=]_P<B<?'SP#_ -@&7_TH>N!_X-]/^3]9?^Q:O/\
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M (Y?FS]Z/^"%W_*.+PC_ -?VH_\ I9+7U]_%7R#_ ,$+O^4<7A'_ *_M1_\
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M?V5;22V?;_@=T?U/P3QMCN&\:L5A'>#^.'22_P ^SZ>ET?@K17UY_P %#/\
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MCYK]4?Q+XG>&-?AVN\7A%S866SZP?\LO+L_D]=_5Z***^\/R,**** "BBB@
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M (1*Y_WJ_I(\/:-:^%]$L]-LH([6RT^!+>"&,;4AC10JJ/8 "OR__P"#=/\
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M.SFE5D_<E[K]'_D[/Y']"E%(C[U!]LTN:_ C^O@HHHH **** "BBB@ HHHH
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MH/?UYP O+$@#FE^)'Q#T7X3>"]1\1>(-0MM)T7286GNKF=MJ0H/YGL%7)8D
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MZCC\1ZQ"^FZ#;A_WLURZX\P#^[$&WL?]D+U90?D;_@VN)E\._%PMU:YTP_\
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MT;+_ !*U?><'Y;#'X/$X:?6WZGY)XD9Q4RK,L#CJ6KCS:=U[MU]Q_4X"<?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPM,QDO+./<7TLGJ1_P!,??MT/]ZOD&OYPS;*<1EV(>&Q*LU_Y-YH_N[ACB;
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M1J/^(=?XU_\ 0>^'O_@PNO\ Y&K]K:*W_P!>LU_F7W'-_P 0GR+M+[S\4O\
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M[:-<V6ZWOXYY/-=H6'"G_8:OTXD3/3'XTX *M?1_ZU8_ZG]1FTXVMYV/A_\
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M_P"#=WXW(I9-=^'I=?NC^T;K_P"1:_:VEKWO]>LT_F7W'R?_ !"C(M[2_P#
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M7_R-7[6?E2CK7T7^O6:?S+[CXS_B%&1-W:E_X$?BF_\ P;N_&Q!_R'OAX/\
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M93E3IP^"FU:WKYOJQE%=A\/OV?O&WQ3NHX_#_A?7-6\SH]O9.\:_[SA=J_\
M J^J_P!GW_@BQXO\930WOCW4K?PO8G!>RMF%S>,/[NY3L3_>!;_=KULPS_+\
M#'FQ-1+RZ_=N?/9)P;G.;34,#AY2\VK+[WH?(7PX^&&O_%SQ7;:'X<TN\UC5
M+QML5O;IN;_:+?W57^)F^5?XJ_4C]@W_ ()A:3^SF;;Q-XL^SZUXRVAXDV[[
M;23_ +']^3_;[?P_WF]X^ G[,/@S]FOP\NG>$]'AL?,'^D7#?O+FZ/J\C?,?
MI]T=@!7H0.T#D5^-\3\=5\P3P^%]RG^+_P EY']1< ^#V$R>2QN9-5:ZV_EA
MZ=WYOY+J ^4#'X5S_P 2OB-HOPF\$:EXC\1:C;:3HNDPM/=W4[;8X4'\ST 4
M9+$@#DU?\4^)M/\ !/AV\U?5+N"PTW38'NKJXGD"1P1HNYG8GHH )S7X3?\
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M25<RJV6E-;+]7Y_D?U-P7P70R2ASS]ZM+XG^B\OS^Y*0# HHHKYD^\"BBB@
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M 0]IC*B@O,^PF7%!.*_/_P"'W_!Q#\(?$>L+;ZQH?C'P]!(?^/J2VAN(H_\
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MG&/6MJ6%JU82JTXWC'?R.&OF.&H584*LTIS^%=_0^FP<BBBBL3N"@]**#TH
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MM7V' V'57,U*7V4W^GZGYMXK8R5#(I1C]N27Z_H?&9;<:7)(Q0>6KWW]@/\
M8#\5?MU_%%=-TQ9M-\,:?(C:SK3)NBM$_N)_?E;^%/Q. ":_9L9C*6&I.O7=
MHH_F;+\OKXVO'#8:/-.6R#]@/]@/Q1^W;\4%TW35ET_PSITB/K6M-'NBLT;^
M!/[\K<[4_$X )K][/V??V?O"_P"S)\,-.\'^#]-CT[1]-7@?>EN)#]^:1_XY
M&[G\.   ?L_?L_>%OV9?ACI_A#PAIL>GZ/IJ< _-+<2'[\LC_P ;MW;Z 8
M'>=*_#^).)*N95;+2FME^K_K0_JC@O@NADE#GG[U:6\OT7E^?X)P&****^9/
MN@HHHH **** "BBB@ Q1THH/- #2<K7RO_P4I_X)L:#^W1X#:ZM1;Z1X^TB!
METK5"N%F'7[//C[T3'H?O1L=R_Q*WU-C(IP -=.#QE;"UE7H.TD>?FF5X?,,
M/+"XJ-XL_E\^*_PKU_X*?$#5/"_BC2[C2=:T>8PW5K,NUE/]Y?[RLN&5E^5E
M966N<^Z:_H!_X*5?\$U_#_[='P_:ZMO(T?Q_H\++I.JE<+,,[OL]QC[T3'H?
MO1L=R_Q*WX1?%CX4^(/@E\0-4\+^*-+NM'UK1YC#=6TPVLI_O+_>5EVLK+\K
M*RLORU^Y\/\ $%',Z.FDUNOU7D?RKQEP;B,DQ&NM%[/]'Y_F<X3O:OZ!?^"/
M?QG?XV?L#^"KFZD\W4-!B?0[EB<M_H[;(\_[7D^4?QK^?H';@U^R/_!N)JTU
MQ^S!XVLY&W0V_B8RQC^[OM8 ?_0!7E\?8>,\N]IU@U_D>[X2XR=+.O8K:<6O
MNU_0_1:BBBOQ<_IT**** "BBB@ HHHH **** "BBB@!IX)K\;?\ @XW_ .3H
M_!7_ &+*_P#I5/7[)-U-?C9_P<<?+^U#X+;_ *EE?_2J>OK."?\ D:0])?D?
MG7BDTLAG?^:/YH^Y/!'_  20_9YUCP/H]U=?#;3VENK&&65Q?WBEF:-23Q-7
MYS_\%;?V(M&_X)Y_&CP7XB^'-]J6DZ;KYENK.W-T9)]*N;5XF#12M\^W]ZC+
MNW,K*WS?=KU'P]_P<8^(/#WANQT^+X5Z6ZV-LD"R'6I/FV(!G;Y/M7DU[X?^
M.7_!;+]H;2=2O='_ ++\-V/^CQWL=L\>DZ+;%\NRNW^MF;'W=S,S*OW57Y?I
MLKPF:83%2KYC5M15[WG?\+L^$S['Y%F."AA,FHWQ#<;<L+-=];+^M3]C_P!E
MWXH7'QG_ &</ OBV\18[SQ%H-EJ,ZJ,*)98$=\>VYC7?#@5@_#CP#8_##P'H
M?AW3$,>FZ!I\.G6J$Y*Q11JB ^^U170*:_,:THNI)PV/W;!PG"A"-5WE97]1
MU%%!Z5F=1\7_ /!>,9_X)YZQ_>_M:P_]&UG_ /! =@O[!,/S -_;MYGGVCJ]
M_P %Y!C_ ()[:S_V%;#_ -'5^=?[%?['7[3'QN^"JZU\+/&&K:+X7:\FB6UM
MO%$^GIYRXWMY4;A>XYK] RW!PQ.0.G4J1@O:;OT/QS/,RJX'B]5J-%U7[*UH
M[[O4_=+Q/MD\.7^UA_Q[R<_\!-?CC_P;N#/[:/BOV\)W!_\ )RSK4O\ _@FY
M^VY!92O-\1-?:%$)<'QY=]-O/\=9/_!NNA7]LWQ2IZ_\(E<9_P# NTK;#9=2
MPN58OV=:-2Z6W34YL=G6(Q^?Y?[?#2HV;^+KMMZ'[2"BBBOSD_; H/2C.*,\
M4 ?-_P#P5!_:D'[)_P"QUXFUVWF^SZ[JB?V/HQ4[7^U3JPWK[QH'D_[9BOQ=
MU/\ 8M\3^'/V)=(^.NZZ2QU#Q ]@L:+M,-NHVI<[OX09TDB_WA'_ 'J^D/\
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M_*/[XI?]@5__ $):[LJ_WVC_ (X_F>1G_P#R+,1_@E^3/@+_ ((8?L=?#/\
M::^&/CB\\>>$[#Q!=:9J4$-K+/+(C1(T;$J-CCTK[M/_  2:_9U'_-,]%_\
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M@45YI[PT\T=3THQS7+_%WXF:9\%_AEKWBK693#IN@6,U_<,#\VR-"V!ZL<8
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M\5/A/X@^"7Q U3PQXHTNYT?6M'F,%S;3+M96_O+_  LK+M967Y65E85^R/\
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M0C6:]A3?-*/\SZ?+_-GRV_\ P0"^ Y7C_A,O;.JK_P#&Z^2?^"MG_!*'PO\
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MQ7@Z4)*7N+65N^BM\CKXQMC4>U.H'2BOC3].6BL%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ QBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ ZT
M444 %&*** "BBB@ HHHH **** "C%%% !BBBB@ HHHH **** "BBB@ HHHH
M**** "CI110 48HHH ,4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 8HHHH **** "BBB@ HHHH **** "BBB@ HHHH .E%%% !1110 444
M4 %&*** "BBB@ HHHH *,444 &*,444 %%%% !1110 4444 %&*** "BBB@
MQ1BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
; "BBB@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139730816008368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 10, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 10,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CENTESSA PHARMACEUTICALS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-04321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3rd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">1 Ashley Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Altrincham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cheshire<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">WA14 2DT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">+44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(0) 203 920 6789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">, ext. 9999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001847903<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1612294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember', window );">American Depositary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.002 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CNTA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=cnta_AmericanDepositarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>cnta-20221110_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cnta="http://www.cnta.com/20221110"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cnta-20221110.xsd" xlink:type="simple"/>
    <context id="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <context id="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001847903</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">cnta:AmericanDepositarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-10</startDate>
            <endDate>2022-11-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl80L2ZyYWc6YjIyODNlY2UzNGYwNDBhYjkzOWUwYTA5MTE3OTlkNjYvdGFibGU6ZWU1M2U0MTIyYzhkNGU2M2ExYmVhZTExNjVkN2E2ODYvdGFibGVyYW5nZTplZTUzZTQxMjJjOGQ0ZTYzYTFiZWFlMTE2NWQ3YTY4Nl8wLTEtMS0xLTc5MjAw_7fd63b6a-3ec0-48d8-9712-0076ade67790">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl80L2ZyYWc6YjIyODNlY2UzNGYwNDBhYjkzOWUwYTA5MTE3OTlkNjYvdGFibGU6ZWU1M2U0MTIyYzhkNGU2M2ExYmVhZTExNjVkN2E2ODYvdGFibGVyYW5nZTplZTUzZTQxMjJjOGQ0ZTYzYTFiZWFlMTE2NWQ3YTY4Nl8xLTEtMS0xLTc5MjAw_5e555197-f182-4c4a-a8f9-b614ca7048a2">0001847903</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6MmI2YzI5YzcxMzIzNDFjODkxM2JjOTY0YzQ2ZTYyM2QvdGFibGVyYW5nZToyYjZjMjljNzEzMjM0MWM4OTEzYmM5NjRjNDZlNjIzZF8wLTAtMS0xLTc5MjAwL3RleHRyZWdpb246YTZmZDZhNTBhNWFhNDk2MDgyNDM5ZTVhNTcwMWEwOTFfOQ_27b34136-1460-4dc6-ac7f-d02fcf9fbfc4">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8yMjE_3700b0d0-a8b0-4377-8c14-76eb2dbac189">2022-11-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk5_0cbbab43-35ef-4b2b-98a2-78c4c01f4143">CENTESSA PHARMACEUTICALS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTAtMS0xLTc5MjAw_c7336306-71e3-478b-88b6-40955909e855">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTItMS0xLTc5MjAw_2aa2d8c5-ca1e-420e-8e8a-8e9adf3de6c8">001-04321</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6YzU5MmE1OWVlYzllNDljM2IwMzBjZDA2MzBmNTc2M2EvdGFibGVyYW5nZTpjNTkyYTU5ZWVjOWU0OWMzYjAzMGNkMDYzMGY1NzYzYV8wLTQtMS0xLTc5MjAw_5cb39cf4-69ff-4a8b-a991-8adea93708a1">98-1612294</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA1_f5c846e0-42e6-46a4-8bf1-2f8a9d04fd6f">3rd Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkw_d3e933ff-a72e-4eb8-a354-0b54121cd9ef">1 Ashley Road</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTAw_aa2403b1-11ad-44a6-a11a-0ff1415159ff">Altrincham</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkx_efb573ba-9436-4510-8241-3f7c7a649e24">Cheshire</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA2_3438ac9a-93f9-469c-ab44-02ff6868d4a5">WA14 2DT</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODkz_85ef4613-5b55-4b6d-b3ec-11d25a5dfcf3">GB</dei:EntityAddressCountry>
    <dei:CountryRegion
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODky_4903b9b8-c610-4dd4-80e8-f37ff76c35e4">+44</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV81MTA_de5bac55-799f-4d39-b788-12de70fb6b58">(0) 203 920 6789</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk2_26369ec7-8b2f-4648-be3c-0943eb6957b2">, ext. 9999</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA3_107f6526-4b75-4e7a-8e1c-affe3f673ad4">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTAy_037b37d1-7fc7-4e51-ac16-dcf49ff4ebd4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODg4_598fd9a6-dd14-40f7-b389-e8a1a6e90051">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODg5_a0ca1558-587b-40d6-a46c-63c2eafc1fa7">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTAtMS0xLTc5MjAw_5f194f66-0500-4118-98ca-65d5393f0305">Ordinary shares, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTItMS0xLTc5MjAw_ea6a365b-3650-4732-bc16-c9faaf918d9a">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9221c934268b4d48bf9a82a914fd8f4d_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8xLTQtMS0xLTc5MjAwL3RleHRyZWdpb246YmE3YzEyMTIxY2I5NDE4MDlhNjVhM2Y5MDI3MjA5YmVfNQ_704a2aac-2b8c-412e-b7f4-183a07dda501">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTAtMS0xLTc5MjAw_062e934d-01d0-431c-91ef-34ba41633725">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.002 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTItMS0xLTc5MjAw_e3612ecd-eb04-46f4-a6cb-8d5b7ef00943">CNTA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i651892de7c4e4852a38efc8a49ecec6f_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGFibGU6ZDE1YTlmODcxY2EzNDM0NmFjYTI4NGUwMjM5MzZiYWUvdGFibGVyYW5nZTpkMTVhOWY4NzFjYTM0MzQ2YWNhMjg0ZTAyMzkzNmJhZV8yLTQtMS0xLTc5MjAw_577a4ac5-e5e0-4937-9df9-ebb6403d0135">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xODk1_3b399baf-e9d0-41e4-9ac1-61ad7336054b">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110"
      id="id3VybDovL2RvY3MudjEvZG9jOjFhZTRmYWE1YzVjYjQ1NmQ5NDVmZjdkYTNkYjA5MjRiL3NlYzoxYWU0ZmFhNWM1Y2I0NTZkOTQ1ZmY3ZGEzZGIwOTI0Yl8xL2ZyYWc6NzgzMDcyYmIxOGUzNDc0Nzg4YjViMjgyZDZkNjUyOTEvdGV4dHJlZ2lvbjo3ODMwNzJiYjE4ZTM0NzQ3ODhiNWIyODJkNmQ2NTI5MV8xOTA0_6cb6bede-aa7e-4424-b78e-d9023bef14cd">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MW\H)=GHXZT '/A#;\;YYK-6^*^MDJ?1WDW!NR4.62G/:2JS-C]MM$R4\8^9
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( )LX:E4'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ FSAJ5<+^WH?N    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ FSAJ59E<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " ";
M.&I5+=C_E3T%  #2%P  &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ FSAJ59^@&_"Q @  X@P   T
M         ( !@ T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " ";.&I5EXJ[
M',     3 @  "P              @ %<$   7W)E;',O+G)E;'-02P$"% ,4
M    " ";.&I5JL0B%C,!   B @  #P              @ %%$0  >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ FSAJ520>FZ*M    ^ $  !H
M     ( !I1(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ FSAJ5660>9(9 0  SP,  !,              ( !BA,  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  U!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>26</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cnta-20221110.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cnta.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="cnta-20221110.htm">cnta-20221110.htm</File>
    <File>cnta-20221110.xsd</File>
    <File>cnta-20221110_def.xml</File>
    <File>cnta-20221110_lab.xml</File>
    <File>cnta-20221110_pre.xml</File>
    <File>cntapr-q32022.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cnta-20221110.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "cnta-20221110_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cnta-20221110.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cnta-20221110_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cnta-20221110_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cnta-20221110.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 33,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 26,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "cnta",
   "nsuri": "http://www.cnta.com/20221110",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnta-20221110.htm",
      "contextRef": "iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.cnta.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cnta-20221110.htm",
      "contextRef": "iab97d551048a447ebe6f4c7a96d69cfc_D20221110-20221110",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "cnta_AmericanDepositarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "American Depositary Shares",
        "label": "American Depositary Shares [Member]",
        "terseLabel": "American Depositary Shares"
       }
      }
     },
     "localname": "AmericanDepositarySharesMember",
     "nsuri": "http://www.cnta.com/20221110",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Ordinary shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cnta.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001847903-22-000082-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001847903-22-000082-xbrl.zip
M4$L#!!0    ( )LX:E7K(5+J,A<  %6:   1    8VYT82TR,#(R,3$Q,"YH
M=&WM/6M7V[BVW\^OT,U9]QQZ+DHLOYVVG)4A@<D,3@H8F.0+2[9DXN#8&=N!
M)+_^;MD.)$ HI>75TK4*)'IM;>VGM+7UZ;_348@N>)(&<?2Y0JI2!?UWZ]/_
M8/S7;P=[J!E[DQ&/,K2=<)IQABZ#;(!.&$_/D9_$(W02)^?!!<4X;[,=CV=)
M<#;(D"S)\HW"I.YR7[=,2<>R3PE6=:YARHF!-8ESS64ZDV5C\ZPN*81+FLDQ
MM5P9JZKF8HN[!B9,LA3)9(:E>9NL3BA7?4HU3_-<5=.9I6J^;S"J,%>R9-45
MPPXRF!W,,$KK4S<)6?"Y,LBR<;U6$Q^K<7)6DR5)KQ6%E475,(C.KVI>7EY6
M+Y6\+K$LJY:7EE775Q(C+_H+IME*Q:NQ@PCZX@+3M2RA4>K'R8AFL!( E2QA
M2<9$7NH$I]Q;Z0@^5\_BBWO[(1J63*R0J\FEP5U0 QI([2][[] ;\!'%091F
M-/)X90E[P=V3@)9*[6;]28K/*!U?M?!IZN:URP(Q08(EL@38+:2OCB"*79KR
M:WRLJTR4)80LJGM11E<:B"^J7CP2D,B$$&E1D_$;5++ ,A3D8/^MYE7K(8W.
M/E=XA(\.*T!JG+*M3R.>420:8_[W)+CX7-F.HPP8"#NS,8#N%9\^5S(^S6HY
MC=2V_O&/?WS*@BSD6P(FO(#G4ZWX\E.MZ-J-V6SK$PLN4)K-0OZYPH)T'-)9
M/8HC#@ $T[JHR)/BSX Q'N5_0GD'N#@)O&+\:7; _<^5@+J6P32-2*I)5=7@
M+M=]U3.HI3/=\GSOM+D !5_C**(C,30/Z@T0#$P(AYV0GE5007/0[32K^\&4
M,^S34"Q7P.!+IAS/W&9\L2<?7/04>\*&K8O^KC7L#G<&?>=@U#MID=[\>-@;
M[I/.:%_K-(]'_2$[[SF=\]ZPH=G#@V!/Z82]>3SMG1Q)_='.H'-BDY[<ECI.
M_[SK[)/^J*?T=UOS_F[[LNNTI5YH2GMR?]8[\?3>L#WK-J&]?#3O[/8N.\W?
M!KWA^;Q[<G39<Z!_IZ5TG?"\,^Q=L-V=P-T]TOLG1\26CR3;:<]Z\\%Y9_=(
MMN76M#<Z!IA;T\[P^+PCM^1N<]'F&,;2HKXS#OO.T;SO[$_MX1_#[NZ^U'=Z
M\YZS$_1/=D(82^Z<["L]IZ=V0O-RSVEE]J$TW7,\F&?C\M3PF:ZX.L4*]R2L
MFLS$ED%D+$F&#@NL&X8E5;9V&GN'K4^UE05^RO5N14"/LVU8\(2&[8CQZ9]\
M]KZ\7UO>Z:WEU;@&JV 9V"<FZ#=/I9B:OH5=G:@>-<3RR)4M"02RJ<)**[?6
MN+;*WPGW><)!^*9WB"4A-NMI+M2!"E"NO.H9"*//E308C4,A3_/O!HD@DA4)
M5)VF#+JHK?91C'\]: E#&D^2_%.N*NHEY17D\1C*6W3$<[);? J8^.P'/$$Y
M0/Q.?;C=_G,5@3<;;RV^6NU]#/B-V>(3:+0D:X+9LR6 PH1@(91OEEV!R=94
M790L/B\&J:T@ZDZ\68 +SU)463==E:FFZUO4E*E%5)^9OLI> &_E]/F9D/S%
M1P:#3<=AX 69S4<N#,$"*"TLRE+?UP\SP(%HLQW2-.WZAUGLG3>F05K96E39
MCD>C.,H+BGX^U>[L_@IU5U"\B<74-6):,N.&IW+5U&2JF-SW@"$L[G%/]W^.
MQ10"1)@&(*AHU.3C. T N[/# 041\>:7M;8JZFI+-E<-++/"/,M7^VO>R2FI
M++<I3;I1$.$!%QY4796KAC;./EX&+!O4B23];R6ONO4I'5,0_&Y2@PZ*OXM^
M;O4F8,8T#,ZBN@=(Y$FE:+PH]^(P3NK_E/)_'WV8)-ALHR"<U?_MP**GJ,,O
MT4$\HM&_-U-P*\#_2 *_J)@&<UXG.@"8?[PL@#:@'V%Y+R9!9 'V4:?MM)KH
MT&DXK<-5F%\AM(>M[:.#MM-N':)&IXE:?VW_WNCLMM!VU[;;AX?M;N<%IR ]
M: HG-!T$T5D61YNH6=VN@CNNJ=8ML)\:./5.X/[U3Z)+'[\)AQEU0[ZHX,8)
M,!P&<$,Z3GE]\<?'A3]4.'\X;_1Q1),S8"HWSK)X5!<,=<&3#(136 Z2CU<4
ME[PF2U5)M@2[9<#7&5L,7')B->?$6L9NEUEFU9+6%TM5<E56R_LN^H<9"&1\
MKBB5&Y,LP2;C#*5Q&# DEN=C69C%XYLE8\H8+'Q='D\1%'U<0F;(_5MS'X$1
M&?+*:V/#'(4[W0,;/:$[L]C:*ASSE_1BI@LOIC,_F]M-;]8;M:?=7?!DFIX$
MWZF]X7%@#\]F_68?/)BC6==I77DQ]J@M]^9MK3?WIO:\#6UVAMWF^=26P3-Q
M>E)OOB^#=S*SY?T;7DP\ZPW[0WL8#COSUMP>VI)]8JO0][PWLK7.\&#8:?;#
MSK ][^\()[6QXL7L*0<A__U@UC]A8U=6]9[3'P%\@X[S&\P9YMT\E^WFV:S3
MM+6^<PS?>Y?V20OFO.-W]T]EPU54HNB8J#JXN,S3,?4,'S-)]CW?\EW?4RM;
M)O[SMO.SHO*N6*F6L_M;%&XOH2! PQVT.@XZ:'WI'CBO'MPO1P>'1PV U^DB
M4,\.Z&!$%-0]0$3;8!]0=P<YO[?0DN:^TMJ-;4<4$_"BWJ[^>PDPA3V,8A\=
M@ V?9&B#E9\Y!8N8IQGB%^)@(,F+.?M0?PYA_26WRUN%M;ZZYRC@P^ _9@/1
M##,ZPS. %?/H34KW8Y7]_D?8E\,+=Q@KW:9]V9G_$?2&+;7OV-!N'[X;!)T3
ML>_UQSG *W><MF8?FS-[V#I5@(]<B4F8FBZ(5\4PL.D1%1LZ=V7F4@]<T<I6
M)[XH7#PB;>8G-O<+V[?$,3^OQ;BH4&)(&6>5KQB1]]B)DK 2*_?JT2O7M$"+
MZ$Q9M2Q?U%M[\@WO WX6I.)4+>M R:\E2Z9@26JGDN>ZU%45K&C<QZHKN]@R
MJ8P-TU,]B?@J414P*<">:!T>-M"7WQL'=F.[=>2TMQM[A^C+WO97Y<H[*S^,
ME>_V!Q_/S65_S\/0#Q/V&ZTI];*<#0OS8\%^FXBF*!US3VQ>,A1$*,A2Y TH
MF!_)A[4D=7NF2Y),*U#^K!1F65534QY#80JIFJK\( K[MC+%U![5\N<"5O\1
M&S?W[, 4;'630 K:>'['2GH6[=F.O#@!#R&/1LF/#;;C290EL^V8K1KP(KBE
MSMD93<9)?.$5M=ZH\5YLS?3F1YH]:I'NR3&,&X:=9CBTY?:E/?]MV&\V9/@]
MZCB>.'2^>< \[#CGLYYSI/5/CH==@+=[8L]A'G-[MW-N-WOPNT<Z\]Z\=WQ[
M:^;4,Q1%5R0=&X0K6#5,%YNFJV-5LC3-DBQN:EIEJQ6=A31B2/P_H2%/UVKI
MDB7NH?85S?/.& ]@C)T@Y- [>%_O%/X "F^O4KA,J<Q,3\,>)1RKLL2QR4T*
M/RS*?(5QW3/%X2?!DJK(Y)VRGY&R'3IMEV?,7B[VW\G\P62^?R-2R',5P+N*
M=<L'SXN"(*>61;!)&:>68D@F)94MR\1$)[)LJ??2^<-.G+[M4.EN^H8^?C1Q
MFU_S'7+:WL@M#!0G*,X&/$'#21*D+/ $%0IG(EBV1C[\6"GP4^!/A. $J0CV
M0$)!H8)UWS%U&U/MZD'UL(I:HW$8SX#45D7>G8B[WR-_+?ZW30/X\@S!4B0\
M3>NOZ*#BA78 &P4FRE][  !YD\KL.[8!G08Y]34/?&0N@;G%P9?0J8I-UR=8
M]DUJ,4GUF>Y7MI2$H9TPCI/OVO/[1>A(_M7HJ'E^><H4;BD*V#/4D,%VYZZ)
MJ:*I6'(UE<C$8Q8'.B*HD0Y"/H.5I>R=EKY.2\JO1DL.&,C@!JJ2XA),"&58
M5:F.*?R))=\G*M&(!G9S9:L19@F8?@,Z>B>D-82T#7]V$R>^?)L;;M\EDJ:G
MW'<U0W$IME0%5!N@%)NR2K#B&X!/7;6XK%:VM@<\'00)OTE$3QGXL+)(7^(T
MHV$_&!>;I[_6.CD-^511%9-Z%JR3XEM@@E@>IJX*JD/V?=W43:92K;)UTB J
MDIO..[.O8_9B<_WV]GNYZRZ:O=&=]^\2!/-34^.^JA,%:ZZF8=75&785[H%Z
M8;)&->9[OE+9.HH"<1?Z3W"36/QPG?**SUQ+PA![)&.A*H,Q#1&?<F^2!1?B
M'!8<6YY^0!L@?( N&?^6\];7,LOKH^1_IRCC(1\/XHBC*'?5-\7F4#AAN>N;
M<)K/LHX6T_S)Q$$I 01&XE^0T6>GJ@5FHP6NAZ<3$7_,P)F5N(E]Q?!]0_<4
MC8/&_S_UUI;J4RI[880U@/9^/?5.;*=QRKCF4@_DKF%9/JR)8F'7,$U,Q*4Y
MR7=U5S-!5DD?D"PIR)(EI!NF]8PWH/=BCX9?A-!XPT<:W\4X\JFL*[K%/0.;
MK@R+I*LF=KGB80E,9^[JEF:X<F5K$Y1'5D46_%NG'E]" R#TBFS NT'< 9.,
M)V7X4[+8A07MY(M0I^@,[(X4-!5'(4T7T=?UKP3(+@4\Z?GF_$M,#+PG[QQE
M X[H>)S$8&:(HQHWGB*7A_&EF* H%/-')OX3^<4V=)""8LYXQ&#B60QS'TW"
MC$8\GJ3A#*4T"U)_EK<L&\0N+")=G/B(@N1*[Z,)] -(C6:+,C\.87#13D2=
M!.+D(T4;*>=HET<\ 2NH'4';27&$U*C*U0+<#V\"YT\H"T^2((-E$0=&DZ@\
M]4AO>Q1N'(<N!1QGL-*_FKQT&LHID0Q?UV0=G D#/ INB" % GZK[W/%UPV%
M,E5$N%N&JGZ\96R46(:56T8S&D^2="+H&3CB8!)RI,I:2=N"J _!;H>& 1!2
MP\O0!C'0]LX!DA6I"A4__.*4>QCGE\Z!YVV00""&PG>RO4&VLU-),5S%8 0;
M/NAZE6L$4X_HF'F^:OF^RMW[R/8:Q6A4XO@VS1*5@FFW1+:M::'A5HE6E:I%
MS5^=;K\D7$A;D7,EO[<J=&+2!3&2O-/OJIEZIIYJENDSBP+!,J)B5?(-["JF
MA;E)"=6Y)4D:64^_@&KL+>'ZJ_*7J S+&^Z'AU%S4?>=GE?HN9VF$YZ\4_5Z
MJM9.J>11HFDFUDS#!:IF.J:J[F%=\61.?8_XU/B15*UPK&YX#Z/JLNZ;H.HE
M ZEP#G@"[L7R_*%&;O&3G*M+9P'FO#X<YE5,;!7YSWZOQ9",1]UKT:JRKOSP
M2QUR5276#^^5F%7+--X(L(!9E3SL$LZ/OM?R!*%Y#XQP=D3:S.*JNC= GDA1
M]0T!C ],G?(<T[L[]/"&@/V!<>DON&0)S4]>#F<C-PXWTF^).'U?L!=8L$YY
M/3-G,;XP"D!A7@X"^.9:JSXR!%U>"0S^2FSP^N5^B90%A;R]QVY^3%;'Y?V+
MPGB9$=G-)=V;-(3+%*Q-@,D)1]VF-^W)+6@#1O!H9]ASVFIG]^C2'MJ:/>\'
M ,_-BQ7GMG,\Z)[TU,Y<U+<E>[XO]TXZ QA+ZCN-F3T_GW=&?PSZQR(%ZXT;
M<II/+-77=2QIDH150DQLF1[%NL8TQ5)\29&TRE8W 8JCR0RE>?;"313%(_@B
M1!<TG' D^%KY*%4E249CD8M1U+I]7G@[8=&O(L\>R\\O)^SNGO 3,G.I^ J]
M]\[)#^#D&S<!.=6IHFLNAA_ R88B8U=L5'J63ZEO$9-9M+*UW7$:WW$)\)TE
M[U6QK^@,];F4[V(?I,@)<^L:.Y2^X2"ZYV;I_?LS"XY:2F_>FME.&^!H VY:
MJMT,!YWA\<"6>YK=;"O03NN-COW._JDAJ52FU,.R:WJ@VF6.7<-7,3$5*AF,
M44TBPGY-&?T;Y8F+D4V3<YYMHKW;F6K^LR[?X*,\Y;NXZ.HR\*NT51^3M/K=
M5OT.=IC=LE4E7>8@L!B6"!.YW(B'+<)]K*@N5<$"50P9;-5%RFUTG7,;'99F
M:^ZD)7P,'\0E11$D$8GHDF7K]IF,VS=\G?[;;</O9)YWV_!;.>>F;:CH(/X]
MAKDKJ5C500M0W7.QR337X+XD8M:^VS;\/HK^FD9X2Z;5#](5[Z;5#^2(FPDE
M#(.JU-,PU\1%7DLQL,5\"QC$U55)81)1M(<;1Z\\%_-_.G$FZ =EA2#=1.XD
M ]47SD3R."#=J#SDRQ^U$P=\89 6ZK$\[UNK4\5.IP,UUF&J^KJ/"=L1$Z>^
M'+DSY.5QF0#6.;H<\#QMQHV@R2!% "('9)P)Y)PE\27@RXM'8Q%(25/$N ]#
MY"GYBF@T25N@\$8H&GQ++$5!&\*\,#[F$6F+RD&>S&\LDOF)R-?B!%IVL7Q'
M7RO'T$6GZE6GXC3ZNMU2M]4U9]/KG]1X,9N\M0;;3WY%;#'P;C[N=C'L7:^[
M9<GD;9KSWQ4 3TX55[$LE_J86\(<)US%%O4(U@EE(N^:I*EN&8.AWXK!>."M
M*7TU2^4+"@K_'M875Z;NE"/!K;CK 4@)'H*X!2D1Q7F$Q23E>2T@WS*Z6[Q<
M&>0"N7A^)Y?=8JQP)@;/I;3@@0CF!B4)OPA2: >RAT:>"#&D7GZ!4506KU$R
MFK"TB.MFZ\([E UZ%=ZQ+%2JS\!I4^=JQD5>\U?ZB.)+1*!*IV"HZRYG'%-J
M<*RJLBIN W',+$E67.X3U6-K8YW6\MF-QY5RM0[XKR<\I.*JXZWGEJXW3G/.
ME*Z;4#>-PTFVOLDZFWW]VTW?^H:445FT&237SL89QV["Z3FF/@Q:I^$EG:65
MVA,^-+4DJXBYZN ,)V!2^;,7NE'=SO@(R55)+C3_[9\'/)V$67[QM0M2IXR$
M$RDQ=Z[$RG8,8DX4/-2J>XGYWRV_NQ&ZE>1_$XDW/'F:4O0%C-D1]?@D=S]!
M5H8>VA"B\%__-&59^EBJ__P3^?@!\!*!@/6$J0<XNQ:\28G%W-B&YG]/\J3,
MJ!#LAQRLKQP$I02AFAO/_B0,4?X^7BF Q_D=9&!%3D$Y!"(@E*TSU1>@Y(&,
M8./YDR0*T@$TH,(\' 1ND"'+JA(A[G,K<'N2)*)R^:"%2'%6WC5ZT+H2^34M
MK,!?$%V]\RRP])5)HHWK"\[+^/D@MO9@(81:=CG8\H!2MB  /P@Y*Y<_7UU0
MHB  ><XP5TK4?*"%GF?PIJ."*I;I;+GR@M@VK]+X78*:1^G$'<)XQ6H*3XVZ
M05@,E0].,Y06\(B=S*2<5+ \I^OL?_ !+):K)TP%]H1A4=X@6WN1IO1>EJ>1
M0WG3>!"W'ST@>E&/3W.J%G?5>.Z- OW"V&4><V\5B'3B@8E3PG$'53[P94&I
M<@<IB]T3#.2;4"^KIY,1D/;LX^L6W%95(NL$][5XOGJ,LI#;)6VGM]'W&D)R
M[[MW^K(21;RCM,#=ZT;=<P<V@TE4E0JSZ%LCF[6J83PNS_V]+TW(BS<J?I)L
M]3=S;MX=<[C06IVX^MC]^>?+@?NBAU)"K__X\)8'G53[_I/MBA7P,>Z5"7SK
MN:(6M0 F>J>>XP7)?'QQ -'U\^KC!/^MY%;P( -L?LF-WH/2Z&6Y<7+'PUQT
M[6[[J^?N!Q(MD=0GI-F7V,3=AF5,T!=PR%%;H!LH4F13:M*,H@VQP$P8PL*E
MR<UW44MT@O[Z[6 /L?+)NV_)(?QS[6X0Y95L;[R6_'"'[=U.PSDZN.,1[7N/
M,%;F$40B4S50;%5[L6WE+TM;L<5.\=^3("F-^(?ZDJ+2P>H6,YN G^71B=@6
MSMWA(C^*& ;<P!06$ KBXN$HEX.'Z M?3'242^JR KB<?!)!F[P[.LD&<0*3
M8^L\BC> ]5P<B3<SZ^O\J3M4SF,F^\)O:WV'J:[J5<OZ\3?PS"HA#WL4[IN
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M8L* 6%!88VD(]6RPM'=,[H&FNU/8(^:@^EB:)U[68+IAPQFB0<?E.GB3<@+
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M\G3XF'[/ZAZH/(C('E4'E;3.:I/VTI[>+&U5S)V3F<Y80 +CB(0$BVR@ IG
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M8^.8^\D\!7_./65J*1[85Z;>ON.RRAE?+#[%U;*N=]F<)^D4$XY)Q!60 H>
MQ"0" E$*%$/<1Y3[ 7);5UGK8FREH$)8WE:T6DFX1&E9 /8PN5_ZQ^'GU%-=
M1VK<%UFV9G_<59;U;H9=9MF:9FV=97O++CNN?M?Y6U%>]96%U1:B&^W'=!B6
MN+P_U\B.--0T9MMC$]'-: -N(MJ0Q/8FHDT-^DX$S<M/^65VET[]V! 12 Q4
M&,6 !)B!4,D80(9#ROQ0H,!Q;Z):'V,;,&KSGO*W+/=*K%WGA$^$NDX+.]$T
M],S0AJ$>T\,:!T>:(3[%?:9)8BVQ]GEBO6DW3UC=ME?ZS<VAZ.U]LI@*I5F
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MPOJ>E9GF7T9,I^]DH#R;W]$2?P@?7SRY_J)_Z?\SS(LG_P=02P,$%     @
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M TUHX6[RE5'LA^3C!]R*,U&T!=RB]M&(!P:AI56\T[\RLJOJ\4+RATY*ZYP
MV$CK>I=!B#F\,,$41>1 QSZK1#!)YH3LX,-!;-2.[U5.^U8E3R!3E&K"RF(7
M)F*)K#):.6QUTH0?SFS?2<>!+6032[&#RSTPY-1(++C" 7T_W9]DAQC'YD<@
MI:5)LZ3"<MZ!#Z"=*I!2+*(Z#+,,#&&@O':Q (Y0"54ZO# ]+$@2_F R:&!
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MM0 @@TK<**)F400.\5L"R)/7_K@).6Y+ )NG)&.1C<KTX^SR7Y_/:WH/L!=
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ME7J7CD8XZOOV&/X9Q:[SX?\!4$L! A0#%     @ FSAJ5>LA4NHR%P  59H
M !$              ( !     &-N=&$M,C R,C$Q,3 N:'1M4$L! A0#%
M  @ FSAJ5;&7G\,H P  OPH  !$              ( !81<  &-N=&$M,C R
M,C$Q,3 N>'-D4$L! A0#%     @ FSAJ59YKK;3T"   DT(  !4
M     ( !N!H  &-N=&$M,C R,C$Q,3!?9&5F+GAM;%!+ 0(4 Q0    ( )LX
M:E67FJ0X!PX  )Z%   5              "  =\C  !C;G1A+3(P,C(Q,3$P
M7VQA8BYX;6Q02P$"% ,4    " ";.&I5ZA..$KH(  #G1P  %0
M    @ $9,@  8VYT82TR,#(R,3$Q,%]P<F4N>&UL4$L! A0#%     @ FSAJ
M5>+'ABBP'@  PVP! !$              ( !!CL  &-N=&%P<BUQ,S(P,C(N
9:'1M4$L%!@     &  8 A@$  .59      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
